Insulin/PI3K signaling promotes rapamycin-sensitive raptor Ser863 phosphorylation in 3T3-L1 adipocytes and HEK293 cells. A, regulation of raptor Ser(P)863 in mTORC1 in 3T3-L1 adipocytes. Differentiated adipocytes were serum deprived, pre-treated with wortmannin (lane 4, left panel) or with rapamycin (lane 8, right panel), and stimulated with insulin. WCL was immunoprecipitated (IP) with preimmune sera (PI) (lanes 1 and 5), anti-raptor antibodies (upper panels, lanes 2–4 and 6–8), or anti-mTOR antibodies (middle panels, lanes 2–4 and 6–8) and immunoblotted (IB) with the indicated antibodies. WCL was also immunoblotted directly (lower panels) with the indicated antibodies to confirm the expected activation and/or inhibition of mTORC1 signaling. B, regulation of raptor Ser(P)863 in HEK293 cells. HEK293 cells were serum deprived, pre-treated with wortmannin (W, lane 4) or rapamycin (R, lane 5), and stimulated with insulin, as indicated for the adipocyte experiment. WCL was immunoprecipitated with preimmune sera (PI) (lane 1) or anti-raptor antibodies (lanes 2–5), and immunoprecipitates were immunoblotted with the indicated antibodies. WCL was also immunoblotted directly with the indicated antibodies to confirm the expected activation and/or inhibition of mTORC1 signaling by the various treatments. C, time course for insulin-stimulated raptor Ser(P)863. HEK293 cells were serum deprived and stimulated with insulin for various amounts of time (5–60 min). WCL was immunoprecipitated with anti-raptor antibodies and immunoblotted with the indicated antibodies. WCL was also immunoblotted directly with the indicated antibodies to confirm the expected activation and/or inhibition of mTORC1 signaling by the various treatments. Note: the asterisk indicates the 70-kDa S6K1 αII species; double asterisks indicate the 85-kDa S6K1 αI species. If not indicated otherwise, all S6K1 immunoblots in this article represent the better studied S6K1 αII species. D, EGF and PMA promote raptor Ser(P)863 independently of PI3K. HEK293 cells were serum deprived and stimulated with 10% FBS (lane 2), insulin (lane 3), EGF (lane 5), or PMA (lane 6). WCL was immunoprecipitated with anti-raptor antibodies and immunoblotted with the indicated antibodies. WCL was also immunoblotted directly with the indicated antibodies to confirm the expected modulation of PI3K (P-Akt), MAPK (P-MAPK (Thr202/TyrY204), and mTORC1 (P-S6) signaling by the various growth factors/mitogens. Note: p44Mapk and p42Mapk are also known as ERK1 and ERK2, respectively. E, MEK/MAPK signaling mediates EGF-stimulated raptor Ser(P)863. Myc-raptor-transfected HEK293 cells (0.5 μg) were serum deprived, pre-treated with UO126 (lane 5), and then stimulated with PMA (lane 3) or EGF (lanes 4–5). WCL was immunoprecipitated with Myc antibodies and immunoblotted with the indicated antibodies. WCL was also immunoblotted to confirm the expected activation/inhibition of MAPK and mTORC1 signaling.